Quantity size:
0.2ml
Concentration:
1mg/ml 磷酸化RET原癌基因抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This gene, a member of the cadherin superfamily, encodes one of the receptor tyrosine kinases, which are cell-surface molecules that transduce signals for cell growth and differentiation. This gene plays a crucial role in neural crest development, and it can undergo oncogenic activation in vivo and in vitro by cytogenetic rearrangement. Mutations in this gene are associated with the disorders multiple endocrine neoplasia, 磷酸化RET原癌基因抗体type IIA, multiple endocrine neoplasia, type IIB, Hirschsprung disease, and medullary thyroid carcinoma. Two transcript variants encoding different isoforms have been found for this gene. Additional transcript variants have been described but their biological validity has not been confirmed. [provided by RefSeq, Jul 2008]
磷酸化RET原癌基因抗体Also known as:
Ret (phospho Y1015); p-Ret (phospho Y1015); Ret Proto-Oncogene; Cadherin-Related Family Member 16; Rearranged During Transfection; RET Receptor Tyrosine Kinase; Cadherin Family Member 12; Proto-Oncogene C-Ret; EC 2.7.10.1; CDHF12; CDHR16; RET51; PTC; Ret Proto-Oncogene (Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1, Hirschsprung Disease) ; Multiple Endocrine Neoplasia And Medullary Thyroid Carcinoma 1; Proto-Oncogene Tyrosine-Protein Kinase Receptor Ret; Hydroxyaryl-Protein Kinase;磷酸化RET原癌基因抗体 RET Transforming Sequence; Receptor Tyrosine Kinase; Hirschsprung Disease 1; Oncogene RET; EC 2.7.10; RET-ELE1; MEN2B; HSCR1;
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, .
●
Immunogen: KLH conjugated synthesised phosphopeptide derived from human Ret around the phosphorylation site of Tyr1015.
●
磷酸化RET原癌基因抗体Predicted Molecular Weight: 124kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user
kl018Hu01α-乳清蛋白(αLA)多克隆抗体Polyclonal Antibody to Alpha-Lactalbumin (aLA)
kl019Hu01血管生成素样蛋白4(ANGPTL4)多克隆抗体Polyclonal Antibody to Angiopoietin Like Protein 4 (ANGPTL4)
kl019Mu01血管生成素样蛋白4(ANGPTL4)多克隆抗体Polyclonal Antibody to Angiopoietin Like Protein 4 (ANGPTL4)
kl019Ra01血管生成素样蛋白4(ANGPTL4)多克隆抗体Polyclonal Antibody to Angiopoietin Like Protein 4 (ANGPTL4)
kl020Hu01淀粉样前体蛋白(APP)多克隆抗体Polyclonal Antibody to Amyloid Precursor Protein (APP)
kl020Ra01淀粉样前体蛋白(APP)多克隆抗体Polyclonal Antibody to Amyloid Precursor Protein (APP)
kl021Hu01连环蛋白β1(CTNNβ1)多克隆抗体Polyclonal Antibody to Catenin Beta 1 (CTNNb1)
kl021Mu01连环蛋白β1(CTNNβ1)多克隆抗体Polyclonal Antibody to Catenin Beta 1 (CTNNb1)
kl021Ra01连环蛋白β1(CTNNβ1)多克隆抗体Polyclonal Antibody to Catenin Beta 1 (CTNNb1)
kl025Hu01神经介素U(NMU)多克隆抗体Polyclonal Antibody to Neuromedin U (NMU)
kl027Hu01泛素激活酶样蛋白(UBE1L)多克隆抗体Polyclonal Antibody to Ubiquitin Activating Enzyme E1 Like Protein (UBE1L)
kl032Hu01磷脂酰肌醇蛋白聚糖1(GPC1)多克隆抗体Polyclonal Antibody to Glypican 1 (GPC1)
kl032Mu01磷脂酰肌醇蛋白聚糖1(GPC1)多克隆抗体Polyclonal Antibody to Glypican 1 (GPC1)
kl033Hu01Dickkopf相关蛋白2(DKK2)多克隆抗体Polyclonal Antibody to Dickkopf Related Protein 2 (DKK2)
kl036Hu01生长激素受体(GHR)多克隆抗体Polyclonal Antibody to Growth Hormone Receptor (GHR)
kl038Hu01谷氨酸半胱氨酸连接酶(GCLM)多克隆抗体Polyclonal Antibody to Glutamate Cysteine Ligase, Modifier Subunit (GCLM)
kl039Hu01表面活性物质关联蛋白D(SPD)多克隆抗体Polyclonal Antibody to Surfactant Associated Protein D (SPD)
kl039Mu01表面活性物质关联蛋白D(SPD)多克隆抗体Polyclonal Antibody to Surfactant Associated Protein D (SPD)
kl039Ra01表面活性物质关联蛋白D(SPD)多克隆抗体Polyclonal Antibody to Surfactant Associated Protein D (SPD)
kl040Hu01波形蛋白(VIM)多克隆抗体Polyclonal Antibody to Vimentin (VIM)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话